Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Study of Amenamevir in Herpes Simplex
NCT02209324Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Nov 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amenamevir in herpes simplex (HSV), Kaposi varicelliform eruption (KVE), sponsored by Maruho Co., Ltd.. Started Nov 2013; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes simplex (HSV)Kaposi varicelliform eruption (KVE)
Beyond the preview
Go deeper on NCT02209324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209324.